you are viewing a single comment's thread.
You're probably right; continues to look horrible.
Made a ton of money here, owned VRTX since the 20's, and sold at the peak.
Unfortunately the HCV drugs won't carry them and the CF isn't enough.
Very bloated corporate structure here, running this like a Biotech firm and not like a business.
From a business point of view this stock can only drift further downwards.